National Research Corporation (FRA:NR1A)

Intra-Cellular Therapies Revenue

National Research had revenue of $33.55M USD in the quarter ending March 31, 2025, a decrease of -4.99%. This brings the company's revenue in the last twelve months to $141.30M, down -4.15% year-over-year. In the year 2024, National Research had annual revenue of $143.06M, down -3.72%.

• Revenue (ttm): $141.30M
• Revenue Growth: -4.15%
• P/S Ratio: 2.11
• Revenue / Employee: $383.96K
• Employees: 368
• Market Cap: 251.73M

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	143.06M	-5.52M	-3.72%
Dec 31, 2023	148.58M	-2.99M	-1.97%
Dec 31, 2022	151.57M	3.61M	2.44%
Dec 31, 2021	147.95M	14.68M	11.01%
Dec 31, 2020	133.28M	5.30M	4.14%